Chapman Wright

Prior to Ensoma, Chapman Wright served as director of process development at Generation Bio, where he guided the development of the company’s novel drug substance production platform. There, his responsibilities included material generation for "in vitro/in vivo" preclinical studies, upstream and downstream process development, and management of CMO operations.